Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?

Rubin MA, Dunn R, Kambham N, Misick CP, O'Toole KM.

Am J Surg Pathol. 2000 Dec;24(12):1634-40.

PMID:
11117784
2.
3.

The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.

Billis A, Guimaraes MS, Freitas LL, Meirelles L, Magna LA, Ferreira U.

J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.

PMID:
18550106
4.

Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.

Obek C, Louis P, Civantos F, Soloway MS.

J Urol. 1999 Feb;161(2):494-8; discussion 498-9. Review.

PMID:
9915434
5.

Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens.

Köksal IT, Ozcan F, Kadioglu TC, Esen T, Kiliçaslan I, Tunç M.

Eur Urol. 2000 Jun;37(6):670-4. Review.

PMID:
10828666
6.

Grading prostate cancer.

Bostwick DG.

Am J Clin Pathol. 1994 Oct;102(4 Suppl 1):S38-56. Review.

PMID:
7524306
7.

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.

Epstein JI.

J Urol. 2011 Sep;186(3):790-7. doi: 10.1016/j.juro.2011.02.2695. Epub 2011 Jul 23. Review.

PMID:
21788055
8.

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability.

Carlson GD, Calvanese CB, Kahane H, Epstein JI.

Urology. 1998 Apr;51(4):525-9. Review.

PMID:
9586600
9.

An update of the Gleason grading system.

Epstein JI.

J Urol. 2010 Feb;183(2):433-40. doi: 10.1016/j.juro.2009.10.046. Epub 2009 Dec 14. Review.

PMID:
20006878
10.

Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Murphy GP, Busch C, Abrahamsson PA, Epstein JI, McNeal JE, Miller GJ, Mostofi FK, Nagle RB, Nordling S, Parkinson C, et al.

Scand J Urol Nephrol Suppl. 1994;162:7-42; discussion 115-27. Review.

PMID:
7817162
11.

[Value of biopsies in staging of prostatic cancer before radical prostatectomy].

Salomon L, Hoznek A, Lefrere-Belda MA, Bellot J, Chopin D, Abbou CC.

Prog Urol. 1998 Dec;8(6):969-76. Review. French.

PMID:
9894255
12.

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la Taille A, Katz AE, Olsson CA, Ennis RD.

Urology. 1999 Mar;53(3):542-7. Review.

PMID:
10096381
13.
14.

[Prognostic factors of prostatic carcinoma].

Helpap B.

Pathologe. 1998 Jan;19(1):42-52. Review. German.

PMID:
9541941
16.
17.

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

Carter HB, Sauvageot J, Walsh PC, Epstein JI.

J Urol. 1997 Jun;157(6):2206-9. Review.

19.

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee.

Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Review.

PMID:
26492179
20.

Supplemental Content

Support Center